bioRxiv · 10.1101/2025.01.13.632780
A prime editing strategy to rewrite the γ-globin promoters and reactivate fetal hemoglobin for sickle cell disease
Abstract
Fetal hemoglobin (HbF) reactivation is a promising therapy for {beta}-hemoglobinopathies. We developed a prime editing strategy that introduces multiple mutations in the fetal {gamma}-globin promoters of patients hematopoietic stem/progenitor cells (HSPCs), boosting HbF expression and offering alternative therapeutic perspectives.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Chalumeau, A., Bou Dames, M., Antoniou, P., Loganathan, P., Mombled, M., Corre, G., Peterka, M., Amendola, M., Giovannangeli, C., Maresca, M., Miccio, A., Brusson, M.. 2025-01-14. A prime editing strategy to rewrite the γ-globin promoters and reactivate fetal hemoglobin for sickle cell disease. https://doi.org/10.1101/2025.01.13.632780
Cite the original work for its findings. Save a collection to share your selection of sources.